NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
enVVeno Medical Corporation (NASDAQ: NVNOW)
NVNOW Technical Analysis
5
As on 26th May 2023 NVNOW SHARE Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.19 & Strong Sell for SHORT-TERM with Stoploss of 0.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVNOWSHARE Price
Open | 0.01 | Change | Price | % |
High | 0.01 | 1 Day | 0.00 | 0.00 |
Low | 0.01 | 1 Week | -0.01 | -50.00 |
Close | 0.01 | 1 Month | -0.04 | -80.00 |
Volume | 24254 | 1 Year | -0.29 | -96.67 |
52 Week High 0.35 | 52 Week Low 0.01 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
NVNOW Daily Charts |
NVNOW Intraday Charts |
Whats New @ Bazaartrend |
NVNOW Free Analysis |
|
NVNOW Important Levels Intraday
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
NVNOW Forecast April 2024
4th UP Forecast | 0.24 |
3rd UP Forecast | 0.17 |
2nd UP Forecast | 0.12 |
1st UP Forecast | 0.08 |
1st DOWN Forecast | -0.06 |
2nd DOWN Forecast | -0.1 |
3rd DOWN Forecast | -0.15 |
4th DOWN Forecast | -0.22 |
NVNOW Weekly Forecast
4th UP Forecast | 0.24 |
3rd UP Forecast | 0.17 |
2nd UP Forecast | 0.12 |
1st UP Forecast | 0.08 |
1st DOWN Forecast | -0.06 |
2nd DOWN Forecast | -0.10 |
3rd DOWN Forecast | -0.15 |
4th DOWN Forecast | -0.22 |
NVNOW Forecast2024
4th UP Forecast | 0.68 |
3rd UP Forecast | 0.47 |
2nd UP Forecast | 0.33 |
1st UP Forecast | 0.2 |
1st DOWN Forecast | -0.18 |
2nd DOWN Forecast | -0.31 |
3rd DOWN Forecast | -0.45 |
4th DOWN Forecast | -0.66 |
enVVeno Medical Corporation ( NASDAQ USA Symbol : NVNOW )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVNOW Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
NVNOW Address
NVNOW Latest News
NVNOW Business Profile
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based devices to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and works as a replacement venous valve to reduce reflux and venous hypertension, as well as to restore proper directional blood flow back to the heart. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service